LIFE INSURA CORP OF INDIA vs NIPPON L I A M LTD

A side-by-side comparison of LIFE INSURA CORP OF INDIA (LICI) and NIPPON L I A M LTD (NAM-INDIA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LIFE INSURA CORP OF INDIA leads LICI vs NAM-INDIA on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

9.54
P/E ratio
49.50
3.09
P/B ratio
16.71
2.28%
Dividend yield
1.76%
₹45.42
EPS
₹23.97

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

37.80%
Return on equity
34.50%
35.00%
Return on capital
44.00%
5.00%
EBITDA margin
69.00%
5.88%
Net margin
52.29%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.61%
Revenue CAGR (3Y)
24.59%
16.86%
Profit CAGR (3Y)
28.36%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹5.48L Cr
Market cap
₹75,730 Cr
₹9.78L Cr
Revenue
₹2,924 Cr
₹57,453 Cr
Net profit
₹1,529 Cr
0.00
Debt / equity
0.02
LIFE INSURA CORP OF INDIA
  • + ["Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 45.6%"]
  • ["The company has delivered a poor sales growth of 7.19% over past five years.", "Tax rate seems low"]
NIPPON L I A M LTD
  • + ["Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 31.9%", "Company has been maintaining a healthy dividend payout of 90.8%"]
  • ["Stock is trading at 16.6 times its book value"]
LIFE INSURA CORP OF INDIA full analysis NIPPON L I A M LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

LIFE INSURA CORP OF INDIA vs NIPPON L I A M LTD: Share Price, Valuation & Which to Buy | DocStoX